This investigation will be carried out on an accelerated schedule, the EMA indicated, and explained that the opinion on the marketing authorization could be issued in a matter of weeks, according to the Dutch press on Wednesday.

The vaccine, which could become the fifth to be licensed in the European Union, uses a different technology from those already validated worldwide.

It is an immunogen based on proteins that trigger a virus-free response, and can be stored at a temperature of between 2 and 8 degrees Celsius, which would ease its distribution.

The WEA noted that the fast evaluation is due to the need to seek alternatives to face the new wave of Covid-19 in Europe.

ef/etc/mgt/gfa